Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

NCT00894504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Panitumumab
DRUG: Carboplatin
DRUG: Gemcitabine

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]